查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587308

商业生物技术分离系统市场：依方法、应用划分 - 2025-2030 年全球预测

Commercial Biotechnology Separation Systems Market by Method (Conventional Methods, Modern Methods), Application (Agriculture, Biopharmaceutical, Cosmetics & Personal Care) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

商业生物技术分离系统市场2023年估值为265.5亿美元，预计到2024年将达到296.5亿美元，复合年增长率为12.14%，到2030年将达到592.4亿美元，预计将达到1000万美元。

商业生物技术分离系统市场包括旨在从复杂混合物中分离生物分子、细胞和颗粒的技术和工艺，可应用于製药、实验室和工业生物加工。该领域的成长是由于对生物製药的需求不断增长、基因组学和蛋白​​质组学的进步以及对高纯度生技药品的需求不断增长而推动的。关键技术包括离心、膜过滤、层析法和电泳，广泛应用于药物发现、蛋白质回收和细胞培养过程。生物技术的应用不断扩大，医学、农业和环境管理成为重要的最终用途。慢性疾病的日益普及需要创新的治疗方案，以及在农业中越来越多地使用生物技术来提高作物产量是关键的成长动力。政府对研发的投资不断增加，加上个人化医疗和生物疗法的日益普及，为市场参与企业提供了利润丰厚的机会。然而，高昂的初始设置成本、困难的法规环境以及与处理先进分离系统相关的技术复杂性等挑战构成了巨大的障碍。儘管如此，这个市场仍显示出充足的创新潜力，特别是在整合人工智慧以提高系统效率、开拓具有成本效益的解决方案和优化分离流程方面。专注于新型生物相容性材料和可扩展系统的研究探索的时机已经成熟。竞争格局的特点是快速的技术进步和旨在提高效率和扩大产品系列的策略联盟。企业应注重技术创新和策略联盟，以巩固市场地位。透过开拓经济实惠、灵活且可靠的生物製程系统来释放重要的市场机会，这些系统可支援可扩展性，同时确保符合监管标准。扩展这些技术以跟上世界生物技术应用的激增对于持续成长至关重要，而针对监管要求的适应性方法可能有助于缓解潜在的挑战。毕竟，市场格局是动态的，成长取决于持续创新和快速适应不断变化的市场需求。

主要市场统计
基准年[2023] 265.5亿美元
预测年份 [2024] 296.5亿美元
预测年份 [2030] 592.4亿美元
复合年增长率（%） 12.14%

市场动态：揭示快速发展的商业生物技术分离系统市场的关键市场洞察

商业生物技术分离系统市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 对个人化药物和细胞疗法的需求不断增长
    • 政府研发经费增加
    • 在塑胶和化学品的商业生产中越来越多地采用磁力分离器
  • 市场限制因素
    • 与商业生物技术分离系统相关的高成本
  • 市场机会
    • 商业生物技术分离系统的不断进步
    • 政府为中小企业采用新技术提供财政支持
  • 市场问题
    • 产品品质监管要求严格的问题

波特五力：引领商业生物技术分离系统市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解商业生物技术分离系统市场的外部影响

外部宏观环境因素在塑造商业生物技术分离系统市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解商业生物技术分离系统市场的竞争格局

对商业生物技术分离系统市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵商业生物技术分离系统市场供应商的绩效评估

FPNV 定位矩阵是评估商业生物技术分离系统市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划商业生物技术分离系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对商业生物技术分离系统市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对个人化药物和细胞治疗方法的需求不断增长
      • 增加政府对研究和开发的资助
      • 在塑胶和化学品的商业生产中越来越多地采用磁力分离器
    • 抑制因素
      • 与商业生物技术分离系统相关的高成本
    • 机会
      • 商业生物技术分离系统的不断进步
      • 政府为中小企业采用新技术提供财政支持
    • 任务
      • 产品品质严格监管要求相关问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章商业生物技术分离系统市场：依方法

  • 介绍
  • 常规方法
    • 离心
    • 层析法
    • 电泳
    • 流式细胞技术
    • 薄膜过滤
  • 现代方法
    • 生物晶片
    • 实验室晶片
    • 磁选
    • 微阵列

第七章商业生物技术分离系统市场：依应用

  • 介绍
  • 农业
  • 生物製药
  • 化妆品/个人护理
  • 饮食

第八章美洲商业生物技术分离系统市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太商业生物技术分离系统市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲商业生物技术分离系统市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • GE HealthCare Technologies Inc.
  • GL Sciences Inc.
  • Hitachi, Ltd.
  • Illumina, Inc.
  • JASCO International Co., Ltd.
  • LECO Corporation
  • Luminex Corporation by DiaSorin SpA
  • Merck KGaA
  • Miltenyi BIoTec BV & Co. KG
  • Novasep Holding SAS
  • PerkinElmer Inc.
  • QIAGEN NV
  • Repligen Corporation
  • Sartorius AG
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Waters Corporation
Product Code: MRR-521BAA36EA74

The Commercial Biotechnology Separation Systems Market was valued at USD 26.55 billion in 2023, expected to reach USD 29.65 billion in 2024, and is projected to grow at a CAGR of 12.14%, to USD 59.24 billion by 2030.

The commercial biotechnology separation systems market encompasses technologies and processes designed to isolate biological molecules, cells, or particles from complex mixtures, instrumental for applications in pharmaceuticals, research laboratories, and industrial bioprocessing. This sector's growth is driven by an increasing demand for biopharmaceuticals, advancements in genomics and proteomics, and the rising need for high-purity biological products. Key technologies include centrifugation, membrane filtration, chromatography, and electrophoresis, utilized extensively across drug discovery, protein recovery, and cell culture processes. Biotechnological applications continue to expand, with healthcare, agriculture, and environmental management emerging as significant end-uses. The growing prevalence of chronic diseases, necessitating innovative treatment options, alongside expanding biotechnological applications in agriculture for improved crop yield, are pivotal growth drivers. The rise in government investments in research and development, paired with the escalating adoption of personalized medicine and biological therapies, offers favorable opportunities for market players. However, challenges such as high initial setup costs, stringent regulatory environments, and technical complexities associated with handling advanced separation systems pose significant barriers. Nonetheless, this market presents ample innovation potential, particularly in enhancing system efficiencies, developing cost-effective solutions, and integrating AI for optimizing separation processes. Research focused on novel biocompatible materials and scalable systems are ripe for exploration. The competitive landscape is characterized by rapid technological advancements and strategic collaborations targeting increased efficiency and expanded product portfolios. Businesses should focus on technological innovation and strategic partnerships to bolster their market position. Developing affordable, flexible, and reliable bioprocessing systems addressing scalability while ensuring compliance with regulatory standards can unlock substantial market opportunities. Scaling these technologies to meet the global surge in biotechnology applications will be crucial for enduring growth, while an adaptive approach towards regulatory requirements will mitigate potential challenges. Ultimately, the landscape is dynamic, with growth contingent upon continued innovation and responsive adaptation to evolving market needs.

KEY MARKET STATISTICS
Base Year [2023] USD 26.55 billion
Estimated Year [2024] USD 29.65 billion
Forecast Year [2030] USD 59.24 billion
CAGR (%) 12.14%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Commercial Biotechnology Separation Systems Market

The Commercial Biotechnology Separation Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for personalized medicines and cell-based therapies
    • Rise in funding by the government for research and development
    • Expanding adoption of magnetic separators for commercial production of plastics and chemicals
  • Market Restraints
    • High cost associated with commercial biotechnology separation systems
  • Market Opportunities
    • Ongoing advancements in commercial biotechnology separation systems
    • Government provides financial assistance to SMEs to introduce novel technologies
  • Market Challenges
    • Problems regarding stringent regulation requirements for product quality

Porter's Five Forces: A Strategic Tool for Navigating the Commercial Biotechnology Separation Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Commercial Biotechnology Separation Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Commercial Biotechnology Separation Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Commercial Biotechnology Separation Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Commercial Biotechnology Separation Systems Market

A detailed market share analysis in the Commercial Biotechnology Separation Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Commercial Biotechnology Separation Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Commercial Biotechnology Separation Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Commercial Biotechnology Separation Systems Market

A strategic analysis of the Commercial Biotechnology Separation Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Commercial Biotechnology Separation Systems Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, GE HealthCare Technologies Inc., GL Sciences Inc., Hitachi, Ltd., Illumina, Inc., JASCO International Co., Ltd., LECO Corporation, Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novasep Holding SAS, PerkinElmer Inc., QIAGEN N.V., Repligen Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Commercial Biotechnology Separation Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across Conventional Methods and Modern Methods. The Conventional Methods is further studied across Centrifugation, Chromatography, Electrophoresis, Flow cytometry, and Membrane filtration. The Modern Methods is further studied across Biochip, Lab-on-a-chip, Magnetic separation, and Microarray.
  • Based on Application, market is studied across Agriculture, Biopharmaceutical, Cosmetics & Personal Care, and Food & Beverage.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for personalized medicines and cell-based therapies
      • 5.1.1.2. Rise in funding by the government for research and development
      • 5.1.1.3. Expanding adoption of magnetic separators for commercial production of plastics and chemicals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with commercial biotechnology separation systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in commercial biotechnology separation systems
      • 5.1.3.2. Government provides financial assistance to SMEs to introduce novel technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Problems regarding stringent regulation requirements for product quality
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Commercial Biotechnology Separation Systems Market, by Method

  • 6.1. Introduction
  • 6.2. Conventional Methods
    • 6.2.1. Centrifugation
    • 6.2.2. Chromatography
    • 6.2.3. Electrophoresis
    • 6.2.4. Flow cytometry
    • 6.2.5. Membrane filtration
  • 6.3. Modern Methods
    • 6.3.1. Biochip
    • 6.3.2. Lab-on-a-chip
    • 6.3.3. Magnetic separation
    • 6.3.4. Microarray

7. Commercial Biotechnology Separation Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Agriculture
  • 7.3. Biopharmaceutical
  • 7.4. Cosmetics & Personal Care
  • 7.5. Food & Beverage

8. Americas Commercial Biotechnology Separation Systems Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Commercial Biotechnology Separation Systems Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Commercial Biotechnology Separation Systems Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alfa Laval AB
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux SA
  • 6. Danaher Corporation
  • 7. GE HealthCare Technologies Inc.
  • 8. GL Sciences Inc.
  • 9. Hitachi, Ltd.
  • 10. Illumina, Inc.
  • 11. JASCO International Co., Ltd.
  • 12. LECO Corporation
  • 13. Luminex Corporation by DiaSorin S.p.A.
  • 14. Merck KGaA
  • 15. Miltenyi Biotec B.V. & Co. KG
  • 16. Novasep Holding SAS
  • 17. PerkinElmer Inc.
  • 18. QIAGEN N.V.
  • 19. Repligen Corporation
  • 20. Sartorius AG
  • 21. Shimadzu Corporation
  • 22. Thermo Fisher Scientific Inc.
  • 23. Tosoh Corporation
  • 24. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOCHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023